US Markets Diverge: Nasdaq Falls on Tech Sell-off as Dow Gains

Wall Street witnessed a split performance on Monday as the S&P 500 and Nasdaq Composite retreated under the weight of megacap technology declines. While tech stocks faced scrutiny over AI spending, the Dow Jones Industrial Average managed to climb, supported by strength in the healthcare and industrial sectors.

Tech Giants and SpaceX Drag Nasdaq Lower

The Nasdaq Composite bore the brunt of the session's volatility, falling 339.67 points, or 1.28%, to close at 26,178.26. The decline was largely driven by a sharp drop in Alphabet, alongside losses in other major players including Meta, Amazon, and Microsoft. Analysts noted that the technology sector remains highly sentiment-driven, with these giants often trading in unison.

Adding to the pressure on the tech-heavy index was a tumble in SpaceX. Despite launching its first-ever debt offering on Monday and reporting a massive cash reserve of approximately $100.8 billion as of June 19, the Elon Musk-led company's stock decline weighed heavily on market sentiment. Investors are increasingly questioning the massive capital expenditure required by "hyperscalers" for artificial intelligence infrastructure, even as the long-term fundamentals of AI data center buildouts remain strong.

Geopolitical Progress and Energy Market Shifts

In a move that provided some relief to the broader economy, oil prices fell following reports of significant progress in U.S.-Iran negotiations. Mediators indicated that officials in Switzerland reached a roadmap for a final deal within 60 days. While tensions remain regarding Lebanon and the Strait of Hormuz, the potential for stabilized energy prices is viewed as a positive catalyst for both consumers and businesses.

However, this geopolitical optimism was partially offset by macroeconomic concerns. A "hawkish" stance from the Federal Reserve under new Chair Kevin Warsh has led investors to prioritize price stability. This outlook has pushed U.S. Treasury yields higher, creating downward pressure on stock valuations.

Economic Data and Key Market Triggers

The market is now pivoting toward critical economic indicators that will dictate the Federal Reserve's next moves. All eyes are on Thursday’s Personal Consumption Expenditures (PCE) data—the Fed's preferred inflation gauge. A reading higher than expected could reinforce the need for aggressive inflation control. Currently, markets are pricing in a 25-basis-point rate hike for September.

Elsewhere in the markets, biotech saw significant movement as Apogee Therapeutics surged following news that AbbVie would acquire the company in a $10.9 billion all-cash deal. Looking ahead, investors will closely monitor Micron Technology’s quarterly results on Wednesday, a key bellwether for the semiconductor and AI hardware cycle.

Key Takeaways

  • Tech Volatility: Megacap tech stocks, led by Alphabet, dragged the Nasdaq down by 1.28% as investors weigh the high costs of AI infrastructure expansion.
  • Geopolitical Impact: Progress in U.S.-Iran talks has eased energy price concerns, though a hawkish Federal Reserve stance continues to push Treasury yields higher.
  • Upcoming Triggers: Markets are bracing for Micron Technology’s earnings and the crucial PCE inflation data, both of which will influence future interest rate decisions.